CGTX logo

Cognition Therapeutics (CGTX) Company Overview

Profile

Full Name:

Cognition Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 8, 2021

Indexes:

Not included

Description:

Cognition Therapeutics (CGTX) is a biotechnology company focused on developing treatments for neurodegenerative diseases, like Alzheimer's. They use innovative approaches to target brain health and improve cognitive function, aiming to enhance the quality of life for patients and their families.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 13, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 19, 24 HC Wainwright & Co.
Buy
Dec 19, 24 Chardan Capital
Buy
Dec 19, 24 B. Riley Securities
Buy
Nov 27, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Chardan Capital
Buy
Nov 4, 24 HC Wainwright & Co.
Buy
Oct 31, 24 Chardan Capital
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Aug 6, 24 B. Riley Securities
Neutral
Aug 1, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Cognition Therapeutics?
  • Does Cognition Therapeutics pay dividends?
  • What sector is Cognition Therapeutics in?
  • What industry is Cognition Therapeutics in?
  • What country is Cognition Therapeutics based in?
  • When did Cognition Therapeutics go public?
  • Is Cognition Therapeutics in the S&P 500?
  • Is Cognition Therapeutics in the NASDAQ 100?
  • Is Cognition Therapeutics in the Dow Jones?
  • When was Cognition Therapeutics's last earnings report?
  • When does Cognition Therapeutics report earnings?
  • Should I buy Cognition Therapeutics stock now?

What is the ticker symbol for Cognition Therapeutics?

The ticker symbol for Cognition Therapeutics is NASDAQ:CGTX

Does Cognition Therapeutics pay dividends?

No, Cognition Therapeutics does not pay dividends

What sector is Cognition Therapeutics in?

Cognition Therapeutics is in the Healthcare sector

What industry is Cognition Therapeutics in?

Cognition Therapeutics is in the Biotechnology industry

What country is Cognition Therapeutics based in?

Cognition Therapeutics is headquartered in United States

When did Cognition Therapeutics go public?

Cognition Therapeutics's initial public offering (IPO) was on October 8, 2021

Is Cognition Therapeutics in the S&P 500?

No, Cognition Therapeutics is not included in the S&P 500 index

Is Cognition Therapeutics in the NASDAQ 100?

No, Cognition Therapeutics is not included in the NASDAQ 100 index

Is Cognition Therapeutics in the Dow Jones?

No, Cognition Therapeutics is not included in the Dow Jones index

When was Cognition Therapeutics's last earnings report?

Cognition Therapeutics's most recent earnings report was on Nov 13, 2024

When does Cognition Therapeutics report earnings?

The next expected earnings date for Cognition Therapeutics is Mar 26, 2025

Should I buy Cognition Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions